September 16, 2014 5:45 PM ET

Biotechnology

Company Overview of Triad Isotopes, Inc.

Company Overview

Triad Isotopes, Inc., a radiopharmaceutical company, supplies radiopharmaceutical products. It operates a network of cyclotrons and nuclear pharmacies. It offers nuclear medicine products that use very small amounts of radioactive materials (radiopharmaceuticals) to image, diagnose, and treat diseases; and cyclotrons for PET imaging. It serves national group purchasing organizations, regional systems, and stand-alone clinics and hospitals. The company was founded in 2006 and is headquartered in Orlando, Florida.

4205 Vineland Road

Suite L1

Orlando, FL 32811

United States

Founded in 2006

Phone:

407 455 6700

Fax:

407 455 6732

Key Executives for Triad Isotopes, Inc.

Chief Executive Officer and President
Age: 49
Chief Financial Officer and Chief Operations Officer
Age: 55
Chief Information Officer
Vice President of Marketing & Communications
Director of Clinical Support Services
Compensation as of Fiscal Year 2014.

Triad Isotopes, Inc. Key Developments

NorthStar Medical Radioisotopes, LLC Signs Letter of Intent with Triad Isotopes, Inc

NorthStar Medical Radioisotopes LLC announced that it has signed a non-exclusive letter of intent with Triad Isotopes Inc. to establish the first commercially viable domestic source of molybdenum-99 (Mo-99), the most widely used radioisotope in medical diagnostic imaging. Under the agreement, NorthStar will work with Triad Isotopes to bring non-uranium-based Mo-99 produced with its proprietary RadioGenix isotope separation system to market. Triad Isotopes will buy and lease the products once the technology has been approved by the U.S. Food and Drug Administration and is commercially available. NorthStar is developing a domestic source of Mo-99 produced without the use of highly enriched uranium (HEU) to help alleviate chronic shortages of the vital medical isotope. This will help meet the goals of the National Nuclear Security Administration's Global Threat Reduction Initiative to reduce and protect vulnerable nuclear and radiological material located at civilian sites worldwide, and to minimize the use of HEU in civilian applications.

Triad Isotopes Inc. Wins $3.1 Million Federal Contract

Triad Isotopes Inc. won a $3,094,013.60 federal contract from the U.S. Department of Veterans Affairs' Medical Center, Minneapolis, for radiopharmaceuticals.

Similar Private Companies By Industry

Company Name Region
ProFibrix, Inc. United States
Trifocal LLC United States
Origen Therapeutics, Inc. United States
Tocagen Inc. United States
The Institute for Bioanalytics, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Triad Isotopes, Inc., please visit www.triadisotopes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.